GGrantIndex
Sort

40,608 grants matching prostate cancer

Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer

$678,424
Moran Amit · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · DE

Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer

$678,424
Moran Amit · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · DE

3D Microscopy with Ultraviolet Surface Excitation (3D-MUSE)

$678,327
David L Wilson · Case Western Reserve University · R01 · FY2020 · EB

Functional Characterization and Development of Therapeutic Paradigms for DNA Damage Repair (DDR)-deficient Lethal Prostate Cancer

$678,271
Goutam Chakraborty · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA

Role of fumarate hydratase loss in development of HLRCC hereditary kidney cancer

$678,223
Leonard Neckers · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Night Shift Work and Hormone Levels in Men

$678,144
Scott Davis · Fred Hutchinson Cancer Research Center · R01 · FY2007 · CA

Selective treatment of acute myeloid leukemia with radioimmunotherapies targeting the active conformation of integrin beta-2

$678,101
Arun P. Wiita · University Of California, San Francisco · R01 · FY2025 · CA

Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ

$678,087
Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL

Administrative Core

$678,084
Brian E Henderson · University Of Southern California · U19 · FY2012 · CA

Personalizing Post-Polypectomy Surveillance for Colorectal Cancer Prevention

$677,942
Jeffrey Kuang Zou Lee · Kaiser Foundation Research Institute · R37 · FY2025 · CA

Multiethnic GWAS and TWAS to Inform Risk Prediction for Prostate Cancer

$677,928
Christopher Alan Haiman · University Of Southern California · U01 · FY2021 · CA

Energetic Factors, Lethal Prostate Cancer, and Survivorship

$677,838
Jing Ma · Harvard School Of Public Health · U54 · FY2011 · CA

Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer

$677,787
Christian Maximillian Schmidt · Indiana University Indianapolis · U01 · FY2021 · CA

NSAIDS and Other Medications in Prostate Cancer Etiology

$677,728
Fred Hutchinson Cancer Research Center · R01 · FY2002 · CA

TRANSLOCATOR PROTEIN FUNCTION IN CASTRATION-RESISTANT PROSTATE CANCER

$677,716
Trustees Of Indiana University · · FY2011 · Department of Defense

Nuclear Factor-kappaB in Ovarian Cancer

$677,683
Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

High-Resolution Breast MRI at 3.0T

$677,646
Brian Andrew Hargreaves · Stanford University · R01 · FY2023 · EB

Development Of Drugs Acting At Adenosine Receptors

$677,639
Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK

Addressing the Biology of Health Disparities by Targeting Geographical Ancestry-driven Variants of Immunity

$677,548
Kevin Sean Kimbro · Morehouse School Of Medicine · R01 · FY2023 · MD

MOLECULAR PATHOGENESIS OF CANCER OF MUTATOR PHENOTYPE

$677,399
Burnham Institute For Medical Research · R37 · FY2000 · CA

Dynamic PET-DECT for Proton Treatment Verification and Response Assessment

$677,356
Xuping Zhu · Massachusetts General Hospital · R01 · FY2017 · EB

Men Moving Forward: A Lifestyle Intervention for African American Prostate Cancer Survivors

$677,350
Melinda R Stolley · Medical College Of Wisconsin · R01 · FY2018 · CA

Career Development in Pediatric and Medical Oncology

$677,301
Soheil Meshinchi · Fred Hutchinson Cancer Center · K12 · FY2024 · CA

Oklahoma Community Clinical Oncology Program (CCOP)

$677,230
Warren Cancer Research Foundation · U10 · FY2003 · CA

MOLECULAR RECLASSIFICATION OF PROSTATIC CANCER

$677,203
University Of Pittsburgh At Pittsburgh · U01 · FY2004 · CA